title: Immunomodulation of human islets results in prolonged in vivo islet graft survival.
authors.affiliation: Department of Surgery, University of Chicago, IL 60637.
authors.forename: Y
authors.initials: Y
authors.lastname: Zeng
authors.forename: L
authors.initials: L
authors.lastname: Peterson
authors.forename: M
authors.initials: M
authors.lastname: Levisetti
authors.forename: M
authors.initials: M
authors.lastname: Torres
authors.forename: A
authors.initials: A
authors.lastname: Montag
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002478:Cells, Cultured; D015925:Cryopreservation; D003921:Diabetes Mellitus, Experimental / Q000628:therapy*; D006085:Graft Survival; D006681:HLA-D Antigens / Q000276:immunology; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D017710:Lymphocyte Transfusion; D051379:Mice; D016513:Mice, SCID; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D006681:HLA-D Antigens